首页> 外文期刊>Hepatitis Monthly >SATURATED FATTY ACID INHIBITS VIRAL REPLICATION IN CHRONIC HEPATITIS B VIRUS INFECTION WITH NONALCOHOLIC FATTY LIVER DISEASE BY TOLL-LIKE RECEPTOR 4-MEDIATED INNATE IMMUNE RESPONSE
【24h】

SATURATED FATTY ACID INHIBITS VIRAL REPLICATION IN CHRONIC HEPATITIS B VIRUS INFECTION WITH NONALCOHOLIC FATTY LIVER DISEASE BY TOLL-LIKE RECEPTOR 4-MEDIATED INNATE IMMUNE RESPONSE

机译:类脂受体4介导的天然免疫反应,饱和脂肪酸抑制慢性乙型肝炎病毒感染的病毒复制。

获取原文
       

摘要

Background: Chronic Hepatitis B (CHB) infection is common in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). The replication level of Hepatitis B Virus (HBV) was inversely correlated with hepatic steatosis. Toll-Like Receptor (TLR) 4-mediated innate immunity plays a pivotal role in the occurrence of NAFLD and controls HBV replication.Objectives: This study aimed to investigate whether the TLR4-mediated innate immunity stimulates the pathogenesis of CHB in patients with NAFLD and to determine whether TLR4 plays a role in inhibiting HBV replication.Materials and Methods: The HBV transgenic mice were randomized into the HBV and HBV/NAFLD groups. HepG2.2.15 cells were treated with different concentrations (0-200 m M) of Stearic Acid (SA) to induce steatosis. The total RNA of the liver tissue was extracted for Real-Time Polymerase Chain Reaction (RT-PCR) detection, and immunohistochemistry or western blot was conducted for further validation. The Enzyme-Linked Immunosorbent Assay (ELISA) analysis was applied to evaluate the production of Interleukin 6 (IL-6), Tumor necrosis factor a (TNF- a ) and Interferon b (IFN- b ). Moreover, viral dynamics were analyzed using HBV DNA and HBV-related antigens (HBsAg and HBeAg).Results: Non-alcoholic fatty liver disease was induced in HBV-transgenic mice fed with High Fat Diet (HFD) for 8 - 24 weeks. Oil red-O staining positive droplets and the content of Triglyceride (TG) were increased in HepG2.2.15 cells treated with SA. TLR4, Myeloid differentiation factor 88 (MyD88), IL-6 and TNF- a expression levels were significantly higher in the HBV/NAFLD group and the steatotic HepG2.2.15 cells than those in their respective controls. Compared to the HBV group, significant reductions in serum levels of HBsAg, HBeAg, and HBV DNA titers occurred in the HBV/NAFLD group at 24 weeks, but the IFN- b level was remarkably increased. Similar data were also obtained from the steatoric HepG2.2.15 cells.Conclusions: Saturated Fatty Acids (SFAs) served as a potential ligand for TLR4 and activated TLR4 signaling pathway, which might be involved in the pathogenesis. Thus, SFAs can accelerate the mechanism of inhibiting HBV replication in CHB with NAFLD.
机译:背景:慢性乙型肝炎(CHB)感染在非酒精性脂肪肝病(NAFLD)患者中很常见。乙型肝炎病毒(HBV)的复制水平与肝脂肪变性呈负相关。 Toll样受体(TLR)4介导的先天免疫在NAFLD的发生中起关键作用,并控制HBV复制。目的:本研究旨在研究TLR4介导的先天免疫是否刺激NAFLD患者的CHB发病。确定TLR4是否在抑制HBV复制中起作用。材料与方法:将HBV转基因小鼠随机分为HBV组和HBV / NAFLD组。用不同浓度(0-200 m M)的硬脂酸(SA)处理HepG2.2.15细胞以诱导脂肪变性。提取肝脏组织的总RNA用于实时聚合酶链反应(RT-PCR)检测,并进行免疫组化或Western blot进行进一步验证。酶联免疫吸附测定(ELISA)分析用于评估白介素6(IL-6),肿瘤坏死因子a(TNF-a)和干扰素b(IFN-b)的产生。此外,使用HBV DNA和HBV相关抗原(HBsAg和HBeAg)分析病毒动力学。结果:高脂饮食(HFD)喂养HBV转基因小鼠8-24周可诱发非酒精性脂肪肝疾病。用SA处理的HepG2.2.15细胞的油红O染色阳性液滴和甘油三酸酯(TG)含量增加。在HBV / NAFLD组和脂肪变性的HepG2.2.15细胞中,TLR4,髓样分化因子88(MyD88),IL-6和TNF-α的表达水平明显高于其各自的对照。与HBV组相比,HBV / NAFLD组在第24周时血清HBsAg,HBeAg和HBV DNA滴度显着降低,但IFN-b水平显着升高。结论:饱和脂肪酸(SFA)可能是TLR4和激活的TLR4信号通路的潜在配体,可能参与了发病机制。因此,SFA可以通过NAFLD加速抑制CHB中HBV复制的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号